To hear more about how we’re leveraging engineered AAVs to discover blood-brain barrier receptors that can be targeted by many therapeutic modalities, check out this talk by Prof. Gradinaru.
Research Highlights
2026: Novel Molecular Shuttle to Deliver Diverse Targeted Therapies to the Brain
2023: A New Mechanism for Crossing the Blood–Brain Barrier
Research
Publications
Talks by Prof. Gradinaru
News
Awards
People
Life @GLab/Caltech
Resources
